International Business Machines stock is getting slammed Monday, becoming the latest perceived victim of rapidly developing AI technology, after Anthropic said its Claude Code tool could be used to ...
LONDON and NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of ...
-- 713,502 bitcoin holdings at a total cost of $54.26 billion, or $76,052 per bitcoin -- 22.8% BTC Yield achieved in FY2025 Capital Markets Highlights -- Largest US equity issuer in FY2025, ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
The company revealed Tuesday morning that it has established the capacity to sell up to $300 million in common stock at its sole discretion. This program is pursuant to a shelf registration statement ...
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- (TSX: DGS, DGS.PR.A) Dividend Growth Split Corp. (the “Fund”) is ...
All dollar amounts expressed are in U.S. dollars. TORONTO--(BUSINESS WIRE)-- Largo Inc. (LGO), a vanadium producer, is pleased to announce the establishment of an at-the-market equity offering program ...
All dollar amounts expressed are in U.S. dollars. Largo Inc. ("Largo" or the "Company") (TSX: LGO) (NASDAQ: LGO), a vanadium producer, is pleased to announce the establishment of an at-the-market ...
Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental ...
Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and ...
Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. The market is pricing Strategy (NASDAQ: MSTR), formerly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results